TY  - RPRT
TI  - CDK9 pharmacological inhibition with PRT2527 has antitumor activity in marginal zone lymphoma models and can improve the effects of BTK, PI3K, and BCL2 inhibitors
AU  - Cannas, E.
AU  - Arribas, A. J.
AU  - Cascione, L.
AU  - Guidetti, F.
AU  - Rinaldi, A.
AU  - Rossi, D.
AU  - Stathis, A.
AU  - Heiser, D.
AU  - Bertoni, F.
PY  - 2026
DO  - 10.64898/2026.02.10.705084
UR  - https://www.biorxiv.org/content/10.64898/2026.02.10.705084v1
ID  - 10.64898/2026.02.10.705084
ER  -